![]() |
|
|
Vol. 301, Issue 3, 803-811, June 2002
-Eudesmol Induces Neurite Outgrowth in Rat Pheochromocytoma
Cells Accompanied by an Activation of Mitogen-Activated Protein Kinase
Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai, Japan
| |
Abstract |
|---|
|
|
|---|
-Eudesmol, a sesquiterpenoid isolated from
"So-jutsu" (Atractylodis lanceae
rhizomas), is known to have various unique effects on the nervous
system. We examined in detail the mechanism by which
-eudesmol
modified neuronal function using rat pheochromocytoma cells (PC-12).
-Eudesmol at concentrations of 100 and 150 µM significantly
induced neurite extension in PC-12 cells, which was accompanied, at the
highest concentration, by suppression of [3H]thymidine
incorporation.
-Eudesmol at concentrations of 100 and 150 µM also
evoked a significant increase in intracellular Ca2+
concentration ([Ca2+]i) in these cells, as
determined by the fura 2 assay. Much of this increase remained even
after the extracellular Ca2+ was chelated by EGTA. The
[Ca2+]i increase induced by
-eudesmol was
partially inhibited by the phosphoinositide-specific phospholipase C
(PI-PLC) inhibitor
1-[6-[[17
-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122) (2 µM) under extracellular Ca2+-free
conditions. Furthermore,
-eudesmol, in a concentration-dependent fashion, caused an accumulation of inositol phosphates.
-Eudesmol (150 µM) promoted phosphorylation of both mitogen-activated protein kinase (MAPK) and cAMP-responsive element binding protein in a time-dependent manner. These phosphorylations were suppressed by the
MAPK kinase inhibitor 2-(2'-amino-3'-methoxyphenol)-oxanaphthalen-4-one (PD98059) (50 µM), U-73122 (2 µM), the calmodulin inhibitor
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W7) (1-10 µM), and the protein kinase A inhibitor N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline
(H89) (1-10 µM).
-Eudesmol-induced neurite extension was
significantly inhibited by both U-73122 (2 µM) and PD98059 (30 µM),
suggesting the involvement of PI-PLC and MAPK in neurite outgrowth.
-Eudesmol, being a small molecule, may therefore be a promising lead
compound for potentiating neuronal function. Furthermore, the drug may
be useful in helping to clarify the mechanisms underlying neuronal differentiation.
| |
Introduction |
|---|
|
|
|---|
The
central nervous system consists of neurons and glial cells. Neurons
play a central role in signal transduction by releasing neurotransmitters. One of the most important characteristics of neurons
is that they cannot, in general, proliferate once they have begun the
process of differentiation. For this reason, neurotrophic factors are
essential for the functional maintenance and organization of neurons.
In the central nervous system, neurons and glial cells secrete
neurotrophic factors, such as nerve growth factor (NGF), brain-derived
neurotrophic factor, neurotrophin 3 (Lessmann, 1998
; Althaus and
Richter-Landsberg, 2000
), interleukin-6 (Schwaninger et al., 1997
), and
glial cell line-derived neurotrophic factor (Lin et al., 1993
). NGF has
pleiotrophic effects on neuronal differentiation and survival
(prevention of apoptosis) in a variety of neurons (Levi-Montalcini,
1987
).
Rat pheochromocytoma cells (PC-12) have been used as an in vitro model
of neuronal differentiation. In response to NGF, these cells extend
neurites and develop characteristics of sympathetic neurons (Greene and
Tischler, 1976
). We have previously reported that a new neurotrophic
factor secreted from 1321N1 human astrocytoma cells caused the
differentiation of PC-12 cells (Obara et al., 1998
). In addition, we
have shown that 1321N1 cell culture medium, conditioned by scabronines
isolated from Sarcodon scabrosus, enhanced the
differentiation of PC-12 cells (Obara et al., 1999a
, 2001
).
"So-jutsu" (Atractylodis lanceae rhizomas), an often
prescribed and important group of Chinese medicines, has various health effects, including the normalization of stomach and intestinal functions and the promotion of diuresis. Sesquiterpenoids, such as
-eudesmol, hinesol, and elemol, were isolated from So-jutsu and
reported to have unique effects on the nervous system. A mixture of
-eudesmol and hinesol was shown to act as a sedative, to prolong sleep induced by hexobarbital, and to have anti-convulsive effects in
mice exposed to electrical stimulation (Yamahara et al., 1977
). The
mechanism by which
-eudesmol mediated these effects has been partially clarified. Thus, Satoh et al. (1992)
showed that
-eudesmol inhibited Na+, K+-ATPase
activity, whereas Kimura et al. (1991)
demonstrated that it acted as a
channel blocker for the nicotinic acetylcholine receptor in skeletal
muscle cells. Furthermore, Tachikawa et al. (2000)
showed that
acetylcholine-induced catecholamine secretion from bovine adrenal
chromaffin cells was suppressed by
-eudesmol by inhibition of
Ca2+ influx.
-Eudesmol, a structural isomer of
-eudesmol, was also shown to be a P/Q-type
Ca2+ channel blocker (Asakura et al., 2000
).
In light of their demonstrated beneficial effects, neurotrophic factors
were suggested as potential therapeutic agents for the treatment of
such neurological diseases as Alzheimer's and Parkinson's disease.
Since these factors are polypeptides of high molecular weight, they
cannot cross the blood-brain barrier and are easily proteolyzed when
administrated peripherally. A useful strategy for addressing this drug
delivery problem is the use of small organic compounds, which
themselves either directly maintain neuronal function or up-regulate
neurotrophic factors. To date, small molecules such as AIT-082 and
SR57746A are known to be promising NGF-like agonists or NGF inducers
(Xie and Longo, 2000
). In the present study, we report the mechanism by
which
-eudesmol promotes neurite outgrowth in PC-12 cells.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
-Eudesmol, propidium iodide, and GF109203X
were purchased from Wako Pure Chemicals (Tokyo, Japan). NGF, carbachol,
W7, and adenosine deaminase were obtained from Sigma Chemical Co. (St. Louis, MO), and H89 was acquired from Seikagaku Corporation (Tokyo, Japan). Fura 2-acetoxymethylester and fluo 3 were purchased from Dojindo (Kumamoto, Japan), and U-73122 and U-73343 were purchased from
Biomol (Plymouth Meeting, PA). [3H]inositol
(23.4 Ci/mmol) was obtained from PerkinElmer Life Sciences (Boston, MA). The anion exchange column (AG1 × 8) and PD98059 were purchased from Bio-Rad (Hercules, CA) and Cell Signaling (Beverly,
MA), respectively.
Cell Culture. PC-12 cells were obtained from the Japanese Cancer Research Bank (Tokyo, Japan) and were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (Cell Culture Laboratory, Cleveland, OH), 5% heat-inactivated horse serum (Invitrogen, Grand Island, NY), penicillin (50 units/ml), and streptomycin (50 µg/ml) in a 5% CO2 incubator at 37°C.
Evaluation of Neurite Outgrowth.
PC-12 cells (1 × 105 cells/ml) were seeded onto 24-well plates and
were cultured for 1 day, after which time drugs were added and the
cells cultured for an additional 1 to 2 days. The cells were then fixed
with 2% paraformaldehyde (Wako Pure Chemicals) in phosphate-buffered
saline (PBS), and cell morphology was assessed under a phase-contrast
microscope. Neurite extension from PC-12 cells was regarded as an index
of neuronal differentiation (Obara et al., 1998
). Processes with a
length equivalent to one or more diameters of the cell body were
regarded as neurites. The differentiation of PC-12 cells was evaluated
by examining the proportion of neurite-bearing cells to total cells in
randomly selected fields. The mean differentiation score was obtained
for more than a 100 PC-12 cells in each well. Data were expressed as
the means ± S.E.M. of three different wells from a single culture.
Measurement of [3H]Thymidine Incorporation. PC-12 cells were seeded onto 24-well plates (1 × 105 cell/ml), and the following day, drugs together with [3H]thymidine (1 µCi/well) (Amersham Biosciences, Piscataway, NJ) were added, and the cells were cultured for an additional 1 to 2 days. After washing twice with ice-cold PBS, the reaction was terminated by the addition of 5% trichloroacetic acid, after which time the plates were kept at 4°C for 60 min. After three washes with ethanol, the radioactivity of [3H]thymidine in the cell lysates was determined by scintillation counting. Data were expressed as the percentage of control.
MTT Assay. PC-12 cells were seeded into 96-well plates (200 µl/well) at a density of 5 × 106 cells/ml. At the end of the drug incubation period, MTT (0.1 mg) (Dojindo) was added to each well, and the plates incubated for an additional 4 h at 37°C. After centrifugation at 350g for 5 min, the medium was replaced with dimethyl sulfoxide. The absorbance of reduced MTT at 595 nm was measured with a plate reader.
Measurement of Intracellular Free-Ca2+ Concentration
by Fura 2.
Intracellular free-Ca2+
concentration ([Ca2+]i)
was measured by the fura 2 assay, as previously described (Obara et
al., 1999b
). Briefly, semiconfluent PC-12 cells cultured in a 150-mm
dish were collected by gentle pipetting and were washed with a modified tyrode buffer (137 mM NaCl, 2.7 mM KCl, 1 mM
MgCl2, 0.18 mM CaCl2, 5.6 mM glucose, 10 mM HEPES, pH 7.4). The cells were then incubated with
fura 2-acetoxymethylester (2 µM) at 37°C for 30 min, after which
time the cells were washed twice with buffer and the fluorescence intensity of fura 2 (excitation wavelength at 340 and 380 nm and emission wavelength at 510 nm) was measured with a fluorescence spectrophotometer (F-2000; Hitachi, Tokyo, Japan). In our preliminary experiments, the Ca2+ responsiveness to
-eudesmol in these suspended PC-12 cells was nearly equivalent to
that seen in attached cells (data not shown).
Measurement of Ca2+ Release from Sarcoplasmic
Reticulum Vesicles by Fluo 3.
Sarcoplasmic reticulum vesicles were
prepared from rabbit skeletal muscle, according to the method described
by Kim et al. (1983)
, in the presence of the protease inhibitors
aprotinin (76.8 µM) (Sigma Chemical Co.) and benzamidine (0.83 mM)
(Sigma Chemical Co.). Briefly, rabbit white muscle was homogenized in 5 volumes of 5.0 mM Tris-maleate, pH 7.0, and centrifuged at
5000g for 15 min. The supernatant was centrifuged at
12,000g for 30 min. The pellet was suspended in 5.0 mM
Tris-maleate containing 90 mM KCl and was centrifuged at
70,000g for 40 min. The pellet obtained after this
high-speed spin, which contained the heavy fraction of sarcoplasmic
reticulum, was resuspended and stored at
80°C. The protein
concentration of the pellet was determined by the method previously
described by Bradford (1976)
, using bovine serum albumin (BSA) as the standard.
Measurement of Ca2+-ATPase Activity.
Ca2+-ATPase activity in sarcoplasmic reticulum
vesicles was measured as follows: Sarcoplasmic reticulum vesicles (40 µg/ml) in 500 µl of basic solution (100 mM MOPS-Tris, pH 7.4, 200 mM KCl, 2.0 mM MgCl2, and 0.4 mM
CaCl2) were preincubated in the absence of drugs
and ATP at 30°C for 5 min. This was followed by a 5-min incubation in
the presence of 400 µl of drugs. The reaction was started by the
addition of 100 µl of ATP (10 mM), which was left on the cells for 3 min (final volume, 1.0 ml). ATPase activity was determined by
measurement of the amount of liberated phosphates, using the malachite
green method as described by Chan et al. (1986)
.
Measurement of Inositol Phosphates.
The accumulation of
total inositol phosphates was measured as follows: PC-12 cells were
cultured in 12-well plates for 2 days at a density of 4 × 105 cells/ml/well. Cultures were then incubated
overnight with [3H]inositol (2 µCi/ml), after
which time they were washed twice with serum-free DMEM-HEPES buffer, pH
7.4. They were then preincubated in DMEM-HEPES containing LiCl (10 mM)
for 10 min, after which they were incubated with drugs for additional
10 min. The reaction was terminated by the addition of 1 ml of ice-cold
5% trichloroacetic acid after aspiration of the medium. The extracts
were washed three times with diethyl ether to remove the
trichloroacetic acid. Diethyl ether in the sample was removed by
storage at 47°C for 30 min. Total
[3H]inositol phosphates were separated by an
anion exchange column (AG-1X8, formate form, 100-200 mesh), as
previously described (Nakahata et al., 1989
).
SDS-Polyacrylamide Gel Electrophoresis and Immunoblotting for Mitogen-Activated Protein Kinase (MAPK) and cAMP-Responsive Element Binding Protein (CREB). Samples used for phospho-MAPK and phospho-CREB detection were prepared as follows: PC-12 cells were seeded onto 6-well plates at a density of 4 × 105 cells/ml. The cells were cultured overnight in serum-free DMEM, after which drugs were added for varying periods of time. The incubation medium was aspirated after the reaction, and the cells were dissolved in Laemmli sample buffer (final concentration, 75 mM Tris-HCl, 2% SDS, 15% glycerol, 3% 2-mercaptoethanol, pH 6.8) and boiled at 95°C for 5 min.
Electrophoresis was performed on 11% acrylamide gels. Proteins were transferred electrically from the gel onto a polyvinylidene difluoride membrane (Millipore, Bedford, MA) by the semidry blotting method. The blots were blocked for 2 h with 1% BSA in Tris-buffered saline at 25°C, and incubated with anti-phospho-MAPKs (Thr 202/Tyr 204) antibody (1:2000 dilution) (Cell Signaling) or anti-phospho-CREB (Ser 133) antibody (1:1000 dilution) (Cell Signaling) overnight at 4°C. The blots were washed several times and then incubated at 25°C for 2 h, with a 1:2000 dilution of alkaline phosphatase-conjugated goat anti-rabbit IgG antibody (Cell signaling) in Tris-buffered saline containing 1% BSA. Blots were developed using a chemiluminescence assay kit (Bio-Rad) and visualized by exposing the chemiluminescence from the membrane to Hyperfilm ECL. The densities of the bands corresponding to phospho-MAPK and phospho-CREB were analyzed by densitometry (Advanced American Biotechnology, Fullerton, CA). After immunoblotting, polyvinylidene difluoride membranes were stained with amide black, and confirmation was made that the protein content in all lanes was equivalent.Immunostaining of Phospho-MAPK and Phospho-CREB. PC-12 cells were seeded onto 24-well plates at a density of 2 × 105 cells/ml. The medium was replaced with serum-free DMEM and the cells were cultivated overnight, after which they were incubated in serum-free DMEM-HEPES containing drugs for 5 min. The cells were then fixed with 2% paraformaldehyde/PBS for 15 min, permeated with 0.5% Triton X-100/PBS for 5 min, and then washed with PBS. After blocking with 5% BSA for 3 h at 37°C, the cells were incubated with anti-phospho-MAPKs antibody (1:500 dilution) or anti-phospho-CREB antibody (1:500 dilution) at 4°C overnight, followed by goat fluorescein-labeled anti-rabbit IgG antibody (1:80 dilution) (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) at 37°C for 60 min. The cells were then incubated with propidium iodide (50 ng/ml) for 30 min to stain the nuclei. The cells were then visualized under a confocal laser microscope (DMRB/E, TCS NT; Leica, Wetzlar, Germany).
Statistical Methods. Data were expressed as the mean values ± S.E.M., and the significant differences were analyzed using an analysis of variance. Tukey's method was used for carrying out the multiple comparisons shown in Fig. 9.
| |
Results |
|---|
|
|
|---|
Effects of
-Eudesmol on Neurite Outgrowth in PC-12
Cells.
To investigate the effect of
-eudesmol on PC-12
cells (Fig. 1), cells were cultured
with it at a concentration of 10 to 150 µM for 48 h, and
morphological changes were observed under the phase-contrast
microscope.
-Eudesmol promoted neurite extension in PC-12 cells
(Fig. 2A). When the percentage of
neurite-bearing cells was evaluated,
-eudesmol, at concentrations of 100 and 150 µM, was found to have
significantly promoted neurite extension (EC50,
>70 µM) to a degree that was similar to that seen with NGF (Fig.
2B). When cell growth was investigated by
[3H]thymidine incorporation, a 48-h incubation
with
-eudesmol (150 µM) was found to have significantly suppressed
proliferation (IC50, >105 µM) (Fig. 2C). Since
the concentration range that caused neurite outgrowth was similar to
the range suppressing proliferation, it was assumed that the
differentiation of PC-12 cells was due to the arrest of cell growth. A
cytotoxic effect was not revealed in this concentration range, as
determined by the MTT assay (data not shown).
|
|
|
[Ca2+]i Increase by
-Eudesmol Mediated
by an Activation of Phosphoinositide-Specific Phospholipase C.
To
examine the mechanism of
-eudesmol-signaling,
[Ca2+]i was measured by
the fura 2 assay.
-Eudesmol caused an
[Ca2+]i elevation in a
concentration-dependent manner in PC-12 cells. The effects of
-eudesmol at concentrations of 100 and 150 µM were significant,
and the maximum response of
-eudesmol was as large as that seen with
carbachol (100 µM). When extracellular Ca2+ was
removed by EGTA, the increase in
[Ca2+]i was partially
inhibited (this inhibition was not statistically significant), although
the preponderance of the
[Ca2+]i increase remained
(Fig. 4). These results suggest that the [Ca2+]i elevation induced
by
-eudesmol primarily resulted from Ca2+
release from intracellular Ca2+ stores in the
PC-12 cells.
|
-eudesmol-evoked Ca2+
release was examined under extracellular
Ca2+-free conditions in PC-12 cells. The PI-PLC
inhibitor U-73122, at a concentration of 2 µM, inhibited the maximum
response of
-eudesmol (150 µM) by about 50%, compared with an
inactive form of the inhibitor U-73343 (2 µM) (Fig.
5A). U-73122 (2 µM) also abolished both
the carbachol and ATP-induced
[Ca2+]i increases in
PC-12 cells (data not shown). When PI-hydrolysis was investigated in
DMEM containing 1.8 mM Ca2+,
-eudesmol and
carbachol resulted in a significant accumulation in PC-12 cells of the
total inositol phosphates by 4.0 and 10.4 times, respectively (Fig.
5B). We also investigated Ca2+ release from
sarcoplasmic reticulum vesicles on which the ryanodine receptor type I
is abundantly expressed by using fluo 3 Ca2+
indicator, but no Ca2+ release was observed in
response to
-eudesmol (data not shown). Furthermore,
-eudesmol
did not inhibit Ca2+-ATPase activity, as
determined by the malachite green method (data not shown), indicating
that
-eudesmol did not directly interact with either the ryanodine
receptor or the Ca2+ pump. These results strongly
suggest that Ca2+ release induced by
-eudesmol
was due to the promotion of PI-hydrolysis.
|
Involvement of MAPK and CREB Activation in
-Eudesmol-Signaling
in PC-12 Cells.
Since MAPK plays a central role in NGF-induced
neurite outgrowth (Cowley et al., 1994
), we wished to determine whether
MAPK activation was involved in
-eudesmol-induced neurite outgrowth in PC-12 cells. After incubation with
-eudesmol (150 µM) for 5 min, phospho-MAPK was clearly detected in the nuclei of PC-12 cells by
immunostaining (Fig. 6A). In addition,
-eudesmol (150 µM) promoted the phosphorylation of MAPKs (ERK1 and
2) in a time-dependent manner (Fig. 7).
Since CREB regulates the expression of genes that play a role in
neuronal functions, such as those encoding catecholamine synthesizing
enzymes and choline o-acetyltransferase, the phosphorylation
of CREB was also examined. After the cells were incubated with
-eudesmol (150 µM) for 5 min, phospho-CREB was detected in their
nuclei (Fig. 6B).
-Eudesmol caused the phosphorylation of CREB in a
time-dependent manner (Fig. 7). The phosphorylation of both MAPK and
CREB that was induced by
-eudesmol was transient. Both
phosphorylations were blocked by PD98059 (50 µM) and U-73122 (2 µM)
(Fig. 8A). PD98059 inhibited MAPK (ERK 1, 2) and CREB phosphorylation by 68.7, 59.0, and 43.9%, respectively, whereas U-73122 reduced the degree of
phosphorylation by 42.7, 43.8, and 38.2%, respectively. These data
indicate that the
-eudesmol-induced MAPK phosphorylation resulted
from activation of PI-PLC and that CREB phosphorylation was dependent
on MAPK activation. Furthermore, both the calmodulin (CaM) inhibitor W7
and the protein kinase A (PKA) inhibitor H89 also reversed the
phosphorylation of MAPK and CREB in a concentration-dependent manner
(1-10 µM) (Fig. 8, B and C). W7 (10 µM) inhibited MAPK (ERK 1, 2)
and CREB phosphorylation by 80.9, 69.5, and 71.0%, respectively,
whereas H89 (10 µM) reduced the degree of phosphorylation by 67.2, 67.7, and 55.0%, respectively. For determinations of involvements of
these molecules, the concentrations of inhibitors used in this study
were referred to these articles (Wang et al., 1998
; Grewal 2000a
,b
). On
the other hand, the protein kinase C (PKC) inhibitor GF109203X (1 µM)
did not affect
-eudesmol-induced MAPK activation (data not shown).
In response to [Ca2+]i
elevation, neuronal cells secrete adenine nucleotides such as ATP and
adenosine, which promote cAMP accumulation through the adenosine
A2a/b receptor (Ohkubo et al., 2000
; Kasai et
al., 2001
). For this reason, we examined the involvement of adenine nucleotides in MAPK activation by using adenosine deaminase (1 unit/ml). However, MAPK phosphorylation induced by eudesmol, was not
inhibited by adenosine deaminase (data not shown). These results suggest that the phosphorylation of both MAPK and CREB were mediated through activation of CaM and PKA.
|
|
|
|
-eudesmol-induced neurite outgrowth in PC-12 cells, the cells were
preincubated with U-73122 (2 µM) or PD98059 (30 µM) for 10 min
before their culture with
-eudesmol (150 µM) for 24 h.
Neurite outgrowth was significantly inhibited by both U-73122 and
PD98059 (Fig. 9A). Although
-eudesmol treatment resulted in the
significant extension of neurites in the presence of U-73122, this did
not occur in the presence of PD98059. Furthermore, neither
-eudesmol (150 µM), U-73122 (2 µM), or PD98059 significantly affected
[3H]thymidine incorporation in these cells
(Fig. 9B).
-Eudesmol increased both PI-PLC activity and MAPK
phosphorylation, and since both U-73122 and PD98059 significantly
inhibited
-eudesmol-induced neurite outgrowth, it appears that
PI-PLC and MAPK play important roles in the differentiation of PC-12 cells.
| |
Discussion |
|---|
|
|
|---|
In the present study, we showed that
-eudesmol caused neurite
outgrowth from PC-12 cells and that this effect was mediated by MAPK
activation. We also demonstrated that the
[Ca2+]i elevation was
triggered by the promotion of PI-hydrolysis, followed by the
phosphorylation of MAPK and CREB.
The concentration range of
-eudesmol that resulted in neurite
outgrowth enhancement was similar to the concentration that suppressed
[3H]thymidine incorporation, suggesting that
the arrest of proliferation triggered cellular differentiation.
Furthermore, the fact that the concentrations of
-eudesmol that
produced statistically significant changes in neurite outgrowth and
[Ca2+]i elevation were
also equivalent suggested that Ca2+-signaling
stimulated neurite outgrowth. With regard to
[Ca2+]i elevation, the
concentration range of
-eudesmol that caused inositol phosphate
accumulation was lower than the concentration that promoted the
[Ca2+]i increase.
Therefore, it was assumed that the part of
[Ca2+]i elevation was due
to other effects of
-eudesmol, such as its inhibition of
Na+, K+-ATPase activity.
This speculation was consistent with the data showing that U-73122 did
not completely inhibit the
[Ca2+]i increase induced
by
-eudesmol (Fig. 5A).
Concerning the mechanism of neurite outgrowth in PC-12 cells,
-eudesmol triggered the phosphorylation of MAPK (Fig. 6 and 7),
which has generally been thought to play a central role in the
NGF-induced differentiation of neurons (Cowley et al., 1994
). MAPK
activation was also assumed to be due to PI-breakdown since U-73122
suppressed the phosphorylation of MAPK (Fig. 8A). Furthermore, neurite
outgrowth induced by
-eudesmol was prevented by PD98059 (Fig. 9).
Hence, it was conceivable that MAPK activation was responsible for
-eudesmol-induced neurite outgrowth. Nevertheless, it is generally
accepted that sustained MAPK phosphorylation is crucial for the
differentiation of PC-12 cells that is induced by NGF (Harada et al.,
2001
). Although our observation (i.e., the transient MAPK
phosphorylation induced by
-eudesmol) is inconsistent with this
notion, we speculate that other signaling molecules that also affect
neurite extension, such as c-Jun N-terminal kinase or
phosphatidylinositol-3-kinase, may account for the transient MAPK phosphorylation.
Starikova et al. (2000)
demonstrated that KCl (40 mM) triggered the
differentiation of PC-12 cells by inducing Ca2+
influx through a voltage-dependent Ca2+ channel.
This result indicated that the
[Ca2+]i increase was
involved in the differentiation of the cells since an
[Ca2+]i increase can
induce MAPK activation (Grewal et al., 2000b
). In spite of that the
Ras/MAPK pathway is an important target for Ca2+-signaling in many cell types and activated
via the Ca2+-sensitive tyrosine kinase Pyk2 (Lev
et al., 1995
), it has been clearly shown that the PKA-dependent
mechanism of Rap-1/B-Raf-signaling pathway predominates in
Ca2+-induced MAPK activation in PC-12 cells
(Grewal et al., 2000a
,b
). In our study, the CaM inhibitor W7 and the
PKA inhibitor H89 reversed
-eudesmol-induced phosphorylation of both
MAPK and CREB (Fig. 8, B and C), suggesting the involvement of
Ca2+/CaM and PKA. Since adenylate cyclase types I
and VIII are CaM-sensitive, the possibility exists that the increased
[Ca2+]i induced by
-eudesmol stimulated the MAPK cascade via PKA as a result of cAMP
accumulation. This speculation is consistent with the report that
increased [Ca2+]i
promoted phosphorylation of MAPK mediated through the
CaM/PKA/Rap-1/B-Raf pathway (Grewal et al., 2000a
,b
). Further study is
needed to confirm the involvement of such molecules (i.e., Rap-1 and
B-Raf) in MAPK phosphorylation induced by
-eudesmol. Regarding
Ca2+/CaM-insensitive signaling, it has been
shown that PKC is also involved in neurite outgrowth in response to NGF
in PC-12 cells, which is mediated through MAPK phosphorylation
(Brodie et al., 1999
). Although classical and novel PKCs are assumed to
be activated as a result of PI-hydrolysis induced by
-eudesmol, the
PKC/MAPK cascade pathway does not play a central role in
-eudesmol-signaling since PKC inhibitor did not inhibit
-eudesmol-induced MAPK phosphorylation (Y. Obara, T. Aoki,
and M. Kusano, unpublished observation).
-Eudesmol also caused the phosphorylation of CREB at Ser 133, which
is a key regulatory site for the control of its transcription activity
(Fig. 6 and 7). CREB phosphorylation was suppressed by both U-73122 and
PD98059 (Fig. 8A), implicating the involvement of PI-hydrolysis and
MAPK activation in this suppression. In addition, both W7 and H89 also
clearly reversed CREB phosphorylation (Fig. 8B and 8C). So far, it has
been shown that the phosphorylation of CREB at Ser 133 occurs via p90
ribosomal S6 kinase (RSK) downstream of MAPK, CaM-kinase, and PKA
(Gonzalez and Montminy, 1989
; Sheng et al., 1991
; Xing et al., 1996
).
Recently, Impey et al. (1998)
showed that the
Ca2+-mediated phosphorylation of CREB in PC-12
cells occurred via MAPK-dependent activation of the CREB kinase RSK2.
PKA was also required for regulation of the nuclear translocation of
MAPK-RSK2, a prerequisite for CREB phosphorylation. Based on this
report, we speculate that the phosphorylation of CREB induced by
-eudesmol is dependent on the MAPK/RSK pathway, which is assumed to
be activated via the CaM/PKA pathway, as described above. However, we
do not deny the possibility of direct phosphorylation of CREB by
CaM-kinase or PKA. It has been shown that NGF potentiates neuronal
functions in PC-12 and bovine adrenal chromaffin cells, which is
accompanied by the induction of the key enzymes in catecholamine
biosynthesis, such as tyrosine hydroxylase and
dopamine-
-hydroxylase, and of ion channels, such as voltage-gated
Na+ and Ca2+ channels
(Acheson et al., 1984
; Bouron et al., 1999
). Since one physiological
role of CREB in NGF-signaling is assumed to be the induction of a
series of these catecholamine-synthesizing enzymes (Ghee et al., 1998
),
then it follows that these enzymes are up-regulated by
-eudesmol
(i.e., functional differentiation). Further study is necessary to
examine the role of
-eudesmol in the functional differentiation of
PC-12 cells.
The concentration-dependence curve of the
-eudesmol-evoked increase
in [Ca2+]i showed a
biphasic response in PC-12 cells (Fig. 3). In addition, the
[Ca2+]i increase was not
completely inhibited by PI-PLC inhibition (Fig. 5A). These results
suggest that there are multiple mechanisms responsible for this
[Ca2+]i regulation.
Previously, Satoh et al. (1992)
demonstrated that
-eudesmol
suppressed Na+, K+-ATPase
and Ca2+-ATPase activity, with
IC50 values of 160 µM and 1.1 mM, respectively. Although the concentration-range of
-eudesmol within which these inhibitory effects were mediated was higher than that used in the
present study, its inhibitory effects on these
Ca2+-regulating ion pumps are thought to be one
of other mechanisms in the
[Ca2+]i increase induced
by
-eudesmol since ouabain caused an increase in
[Ca2+]i by inhibition of
Na+, K+-ATPase (Hochstrate
and Schlue, 2001
). In contrast to the results of our study, Tachikawa
et al. (2000)
demonstrated that
-eudesmol prevented the
Ca2+ influx induced by both acetylcholine and
high KCl in a concentration-dependent manner in cultured bovine adrenal
chromaffin cells and that the acetylcholine-induced secretion of
catecholamines was consequently abolished by
-eudesmol. One
interpretation of these conflicting findings is that high
concentrations (100 µM) of
-eudesmol affect at least two distinct
sites that promote Ca2+ release and inhibit
Ca2+ influx, respectively, although its effects
on Ca2+ release predominates in PC-12 cells. In
other words, since Ca2+ release was lacking in
bovine adrenal chromaffin cells, it was assumed that the
[Ca2+]i increase was not
observed (Tachikawa et al., 2000
).
PI-PLC is classified into three major groups (
,
, and
) on the
basis of molecular mass, deduced amino sequence, and immunological cross-activity. So far, 10 different mammalian PI-PLC isoenzymes (
1-4,
1-2, and
1-4) have been characterized (Rebecchi and
Pentyala, 2000
). PLC-
has been shown to be regulated by G-proteins,
such as the
-subunits of a pertussis toxin-insensitive Gq family of G-proteins and 
-subunits of
G-proteins, whereas PLC-
was shown to be regulated by tyrosine
phosphorylation by the action of tyrosine kinases of growth factor
receptors or members of the src family, such as Src and Lyn
(Rebecchi and Pentyala, 2000
). In contrast to PLC-
and -
isoenzymes, the physiological role and regulation of PLC-
family
isoenzymes have not been determined clearly, despite their wide
distribution. It has been shown that PC-12 cells express at least these
three PLC isoenzymes (
,
, and
) in sufficient quantities to be
detected by Western blot (Ryu et al., 1990
); however, the detailed
expression patterns of the isoenzymes in each family have not been
clearly defined. Which isoenzymes of PLC are involved in
-eudesmol-signaling and whether
-eudesmol directly activates PLC
also remain to be investigated.
In conclusion, our data suggest that
-eudesmol induces neurite
outgrowth in PC-12 cells, which is accompanied by MAPK activation.
-Eudesmol, being a small molecule, may be a promising lead compound for potentiating neuronal function. In addition, the drug may be useful
in helping to clarify the mechanisms underlying neuronal differentiation.
| |
Footnotes |
|---|
Accepted for publication February 19, 2002.
Received for publication December 11, 2001.
This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (01532 to Yu.O.).
Address correspondence to: Dr. Yutaro Obara, Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan. E-mail: yutaro{at}mail2.pharm.tohoku.ac.jp
| |
Abbreviations |
|---|
NGF, nerve growth factor;
AIT-082, 4-[[3-(1,6-dihydro-6-oxo-9-purin-9-yl)-1-oxopropyl]amino]benzoic
acid;
SR57746A, 1-[2-(naphth-2-yl)ethy]-4-(3-trifluoromethyl
phenyl)-1,2,5,6-tetrahydropyridine hydrochloride;
GF109203X, 3-[1-[-3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione
monohydrochloride;
W7, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide
hydrochloride;
H89, N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline;
U-73122, 1-[6-[[17
-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione;
U-73343, 1-[6-[[17
-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidine-dione;
PD98059, 2-(2'-amino-3'-methoxyphenol)-oxanaphthalen-4-one;
DMEM, Dulbecco's modified Eagle's medium;
PBS, phosphate-buffered saline;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium;
BSA, bovine
serum albumin;
MOPS, 4-morpholinepropanesulfonic acid;
MAPK, mitogen-activated protein kinase;
CREB, cAMP-responsive element binding
protein;
PI-PLC, phosphoinositide-specific phospholipase C;
[Ca2+]i, intracellular Ca2+
concentration;
CaM, calmodulin;
PKA, protein kinase A;
PKC, protein
kinase C;
RSK, ribosomal S6 kinase;
PC-12, pheochromocytoma cells.
| |
References |
|---|
|
|
|---|
-Eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion.
Brain Res
873:
94-101[CrossRef][Medline].
plays a role in neurite outgrowth in response to epidermal growth factor and nerve growth factor in PC12 cells.
Cell Growth Differ
10:
183-191
-eudesmol on the nicotinic acetylcholine receptor channel in mouse skeletal muscles.
Neuropharmacology
30:
835-841[CrossRef][Medline].
.
Mol Pharmacol
59:
1287-1297
by protein kinase C.
J Biol Chem
265:
17941-17945This article has been cited by other articles:
![]() |
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al. Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 739 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakajima, T. Yamakuni, K. Matsuzaki, N. Nakata, H. Onozuka, A. Yokosuka, Y. Sashida, Y. Mimaki, and Y. Ohizumi Nobiletin, a Citrus Flavonoid, Reverses Learning Impairment Associated with N-Methyl-D-aspartate Receptor Antagonism by Activation of Extracellular Signal-Regulated Kinase Signaling J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 784 - 790. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||